Western Occupational & Environmental Medical Association
mapCALIFORNIA | NEVADA | HAWAII | UTAH | ARIZONA
Leading Occupational & Environmental Medicine

CME Webinars Calendar

WOEMA’s Education Committee offers CME Webinars on topics relevant to the practice of occupational and environmental medicine. These webinars can be accessed by calling a toll-free 800 number and viewing the Powerpoint presentation using your Internet browser from your own computer. WOEMA members will be notified in advance of the dial-in phone number and the URL link to access the slides. When the CME Webinar is offered live, members will have the opportunity to send questions to the presenter and have those answered in real-time on the live broadcast. Following the live broadcast, WOEMA members may view and listen to the webinar on-line and then complete the questionnaire in order to receive credit.

WOEMA CME Webinar Registration Fees
WOEMA/ACOEM Member – Free
Non-Member Physician – $20
Non-Member, Non-Physician – $15

Click here to listen/view past webinar presentations.


TOPIC: The Occupational Neurology Fitness for Duty Evaluation for the Safety Sensitive Worker
To Air on August 27, 2014, 12pm PST

Speaker: Jonathan Rutchik, MD, MPH, FACOEM

Occupational Medicine practitioners are often faced with challenging decisions when a patient with nonindustrial neurological conditions requests a return to work. Many of these are commercial drivers, police officers, fire fighters, hazardous waste workers, or aviation pilots where there is a potential safety risk to self or others.  In fact the newest FMCSA, NFPA and FAA regulations require clearance from a “neurologist who understands the functions and demands of commercial driving.”  In this presentation, Dr. Jonathan Rutchik, an ACOEM fellow, Associate Professor in Occupational Medicine at UCSF and physician board certified in both Neurology and Occupational Medicine will discuss neurological conditions such as head trauma, stroke and seizure, multiple sclerosis, tremor and medication use in patients with safety sensitive positions.   The participant will become familiar with the algorithms necessary when evaluating these patients and when a neurologist consultation is necessary.

Learning Objectives – Participants will be able to:

  • Define safety sensitive positions in the workplace, the American Disabilities Act (ADA) and which neurological conditions are commonly of concern in this arena
  • Define the most important issues regarding neurological conditions and an employee’s risk to self or others
  • Interpret how neuroepidemiology can help with predicting risk in neurological patients so as to appropriately judge their fitness in an era of the ADA

Dr. Jonathan Rutchik is a physician board certified in both neurology and occupational and environmental medicine.  An ACOEM fellow and Associate Professor at UCSF, he evaluates and treats injured workers and those exposed to industrial or environmental agents in his private practice in 5 locations in the San Francisco bay area.  Dr. Rutchik also provides expert consulting on various topics related to Occupational and Environmental Neurology and Clinical Neurotoxicology including fitness for duty in commercial drivers, firefighters, police and aviators as well as disability and chronic pain and neurological trauma.

Click here to register for the August 27th WOEMA Webinar with Dr. Rutchik

CREDIT: WOEMA is accredited by the Institute of Medical Quality/California Medical Association to provide continuing medical education for physicians. WOEMA takes responsibility for the content, quality, and scientific integrity of this CME activity.

WOEMA designates this educational activity when combined with completion and submission of the on-line questionnaire, for a maximum of 1.0 AMA PRA Category 1 CreditTM. CME Certificates are issued and e-mailed to those who successfully participate and complete the webinar.


TOPIC: Hypertension Update: New JNC8 Guidelines vs. Old Federal Motor Carrier Safety Regulations (49 CFR 391.41 (b)(6))
Aired on June 25, 2014, 12pm PST

Speaker: Joel Handler, MD

Hypertension recommendations have changed with the new Joint National Committee on High Blood Pressure (JNC8) evidence-based guideline, and are finding their way into general practice.  It is important for primary care practitioners to understand the rationale for the new guideline.  Delivery of care is dependent upon accurate blood pressure measurement, and participants will learn to avoid common errors.

Learning Objectives – Participants will be able to:

  • Recognize the JNC8 recommendations for the treatment of hypertension
  • Identify and avoid common errors in blood pressure measurement
  • Explain the elements of protocoled care that are associated with a high rate of hypertension control

Dr.  Joel Handler has been the national Kaiser Permanente Clinical Hypertension Lead since 2006, and since 2005 has been the southern California Kaiser Permanente region hypertension lead. In these roles he is responsible for the development and periodic review of hypertension treatment guidelines as well as their implementation. He created a referral clinic for resistant hypertension in 1992 and sees KP patients throughout southern California. Dr. Handler is currently certified in internal medicine, critical care medicine, geriatrics, and is an American Society of Hypertension Specialist in Clinical Hypertension. In 2011 he became a Fellow of the American Society of Hypertension. In his daily clinical practice, he sees intensive care unit patients in the mornings, as well as a primary care panel and hypertension referral patients in the afternoons.

[Download Presentation]

CREDIT: WOEMA is accredited by the Institute of Medical Quality/California Medical Association to provide continuing medical education for physicians. WOEMA takes responsibility for the content, quality, and scientific integrity of this CME activity.

WOEMA designates this educational activity when combined with completion and submission of the on-line questionnaire, for a maximum of 1.0 AMA PRA Category 1 CreditTM. CME Certificates are issued and e-mailed to those who successfully participate and complete the webinar.


TOPIC: Latent TB diagnosis with the Quantiferon Assay- Providing Answers and Raising Questions
Aired on April 23, 2014.

Speaker: Madeline Slater, MD

Despite the all-time low incidence of tuberculosis (TB) in the United States, large numbers of U.S. healthcare workers (HCWs) are screened routinely for latent TB infection (LTBI). IFN-gamma release assays (IGRAs), such as the QuantiFERON-TB Gold In-Tube (Qiagen/Cellestis, Carnegie, Australia) test (QFT) and T-spot (Oxford Immunotec, UK) are increasingly replacing the tuberculin skin test (TST) for occupational screening. More than 70 U.S. medical institutions have adopted the QFT assay to serially test hundreds of thousands of hospital employees each year. In principle, IGRAs have equivalent sensitivity compared with the TST, with improved specificity in bacille Calmette-Guérin vaccinated individuals and individuals with nontuberculous mycobacterial infection. Additionally, IGRAs improve the logistics and economics of TB screening because, unlike the TST, they do not require trained readers, a return visit, or baseline two-step testing for annual screening. However, in practice, IGRA results have proved more dynamic in serial testing than anticipated. Early adopters of the QFT assay for occupational screening are now reporting major concerns with interpretation of the high conversion and reversion rates using the manufacturer’s recommended cutoff of simple negative to positive change.

Learning Objectives – Participants will be able to:

  • To define IGRAs and describe how they are performed
  • To define performance characteristics of IGRAs and compare to those of the TST
  • To review guidelines on the usage of IGRAs and discuss clinical scenarios
  • To describe the observed variability in serial testing; to list potential sources of variability; to describe quality assurance measures to minimize variability
  • To outline areas of clinical uncertainty

Dr. Slater is currently a senior postdoctoral fellow for the Infectious Diseases Division at Stanford University School of Medicine. She has focused the past years primarily on IGRA research and has published multiple highly regarded journal articles from studies conducted both domestically and abroad. Clinically, she works as a TB and STD physician for the San Mateo Department of Public Health. Additionally, she serves as a consultant to the CDC on a large-scale project in Thailand and Vietnam evaluating latent TB acquisition in health care workers.

[Download Presentation]

CREDIT: WOEMA is accredited by the Institute of Medical Quality/California Medical Association to provide continuing medical education for physicians. WOEMA takes responsibility for the content, quality, and scientific integrity of this CME activity.

WOEMA designates this educational activity when combined with completion and submission of the on-line questionnaire, for a maximum of 1.0 AMA PRA Category 1 CreditTM. CME Certificates are issued and e-mailed to those who successfully participate and complete the webinar.


TOPIC: Opioid Prescribing: New FDA Labeling and New Guidelines
Aired on February 26, 2014.

Speaker: Scott Fishman, MD

Description: This webinar will review current data and recommendations/guidelines from regulators and professional societies on the use of opioids and chronic pain. The risk vs. benefit analysis will be framed as an essential element of treatment decisions and thus emphasis will be placed on close attention to current data of risks compared with the benefits associated with chronic opioid prescribing. Recommendations from regulatory organizations including the recent labelling of chronic opioids by the FDA as well as recently revised model policy on opioid prescribing by the Federation of State Medical Boards will be reviewed.

Learning Objectives – Participants will be able to:

  • Understand the legal issues that relates to pain
  • Understand emerging legislation related to pain
  • Understand areas where law and practice may conflict

Dr. Scott M. Fishman is Professor and the Charles and Patricia Fullerton Endowed Chair of Pain Medicine, Chief of the Division of Pain Medicine, and Executive Vice Chair for the Department of Anesthesiology and Pain Medicine at the University of California, Davis. His medical degree is from the University of Massachusetts Medical School. Formal clinical training is in Internal Medicine (Greenwich/Yale University School of Medicine) and Psychiatry (Massachusetts General/Harvard Medical School).

Dr. Fishman lectures on all aspects of pain control including preventing prescription drug abuse. Dr. Fishman has authored many peer-reviewed articles in medical journals, book chapters, and other scholarly reviews. He is senior editor of the journal Pain Medicine and serves on the editorial boards of other medical journals.

[Download Presentation]

CREDIT: WOEMA is accredited by the Institute of Medical Quality/California Medical Association to provide continuing medical education for physicians. WOEMA takes responsibility for the content, quality, and scientific integrity of this CME activity.

WOEMA designates this educational activity when combined with completion and submission of the on-line questionnaire, for a maximum of 1.0 AMA PRA Category 1 CreditTM. CME Certificates are issued and e-mailed to those who successfully participate and complete the webinar.


2013 Presentations

2012 Presentations

2011 Presentations

2010 Presentations

2009 Presentations


Click Here to Listen and/or Download Webinar Presentations